CClinicalTrials.gg
CompletedNCT02845141Updated Jan 19, 2018

Synthetic Bone Graft Substitute vs. Autologous Spongiosa in Revision Anterior Cruciate Ligament Reconstruction

An interventional study of Actifuse and bone graft in Anterior Cruciate Ligament Injury, sponsored by Berufsgenossenschaftliche Unfallklinik Ludwigshafen. Completed at 1 site in Germany. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-01-19.

Sponsored by Berufsgenossenschaftliche Unfallklinik Ludwigshafen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The overall objective is the histological and radiological assessment of bony consolidation of the tibial/femoral tunnel using either bone graft substitute (Actifuse) or autologous spongiosa in patients undergoing revision anterior cruciate ligament reconstruction.

Clinical correlation with the histological and radiological results using the SF36 questionnaire.

Read the detailed description

* Study design: Monocentric, prospective, randomised study. Patients who need revision anterior cruciate ligament reconstruction and show a tunnel enlargement of >10mm will have a first operation filling the tibial/femoral tunnel either with bone graft substitute (Actifuse) or autologous spongiosa.

5 - 6 months after this first operation a CT will be performed to assess the bony consolidation of the former tibial/femoral tunnel. An MRI will be performed to assess vitality of the bone substitute.

An osseous biopsy will be taken from the tibial/femoral tunnel at the revision anterior cruciate ligament reconstruction approximately 6 months after bone grafting.

Clinical evaluation will be performed 6 weeks, 3 months and 6 months postoperative. At 6 months postoperative additional radiological evaluation and clinical assessment using the SF36 questionnaire will be performed.

  • Treatment: Either autologous spongiosa or Actifuse (MIS applicator) will be administered by the investigator as a bone graft substitute for tunnel enlargement in patients undergoing revision anterior cruciate ligament reconstruction.
  • Duration of Participation: The participation of each subject will be approximately 12 months.

Each subject will undergo revision anterior cruciate ligament reconstruction approximately 6 months after bone grafting. A biopsy will be taken at this operation. A clinical and radiological follow up is planned for further 6 months.

* Subjects: Male and female patients ≥ 18 years. Approximately 40 patients who undergo revision anterior cruciate ligament reconstruction will be included in the study.

Inclusion criteria: Patients in need of revision anterior cruciate ligament reconstruction Exclusion criteria: Infection, wound healing complications

02

Conditions studied

  • Anterior Cruciate Ligament Injury

Keywords

  • ACL
  • Revision surgery
  • tunnel enlargement
  • bone substitute material
  • bone graft
03

In context

Anterior Cruciate Ligament Injuries

512 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 164 are open to participants now.

This study's enrollment of 40 is below the median of 56 across 373 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

Berufsgenossenschaftliche Unfallklinik Ludwigshafen is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients in need of revision anterior cruciate ligament reconstruction

Exclusion criteria

Exclusion Criteria:

  • Infection, wound healing complications
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Actifuse

    Actifuse to fill bone tunnel

    Procedure: Actifuse

  • Active comparator
    bone graft

    bone graft to fill bone tunnel

    Procedure: bone graft

Interventions

  • ProcedureActifuse

    bone tunnel filled with Actifuse

    Also known as: Baxter Actifuse MIS

  • Procedurebone graft

    bone graft to fill bone tunnel

06

What researchers measure

Primary outcomes

  1. histological assessment of bony consolidation

    histological probes during second intervention to measure bony ingrowth into bone substitute material

    Time frame: 6 months postop

Secondary outcomes

  1. Tegner Activity Score

    functional score

    Time frame: 3, 6 and 12 Months

  2. IKDC Score

    functional score

    Time frame: 3, 6 and 12 Months

  3. stability measurement using KT1000

    functional score

    Time frame: 3, 6 and 12 Months

  4. SF36-Score

    health score

    Time frame: 3, 6 and 12 Months

07

Study locations

1 site
  • BG Unfallklinik
    Ludwigshafen, 67071, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02845141
Lead sponsor
Berufsgenossenschaftliche Unfallklinik Ludwigshafen
Responsible party
Jan von Recum (Dr. med., Berufsgenossenschaftliche Unfallklinik Ludwigshafen) — Principal investigator
First posted
Jul 27, 2016
Start date
Mar 2013
Primary completion
Sep 2016
Completion
Jul 2017
Last update
Jan 19, 2018

Study contacts

Jan von Recum, MD
principal investigator · BG Unfallklinik Ludwigshafen
Marc Schnetzke, MD
study chair · BG Unfallklinik Ludwigshafen

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion